Bacterial efflux pumps have emerged as antibiotic resistance determinants and confers multidrug resistance to a broad range of antimicrobials as well as non-antibiotic substances by potentially extruding them out. These are also associated with the virulence and biofilm formation. Thus, development of inhibitors against these effective antibacterial targets can be a highly beneficial approach in order to reverse the multidrug resistance (MDR) in the clinical relevant strains. A keen study on the efflux of foregoing or commonly used antibiotics will contribute in finding substrates that could bind efficiently with these efflux pumps. In the present study, we have explored efflux pumps belonging to Resistance-Nodulation-Division (RND) family as they are found prevalent in gram negative pathogens such as A. baumannii. The two RND efflux pumps under consideration are AdeABC and AcrAB-TolC. For comparative analysis, a non-RND family efflux pump i.e. NorM is selected here. We employed a series of computational techniques ranging from molecular docking to binding free energy estimation and molecular dynamics simulations to determine the binding affinity for different classess of drugs namely aminoglycosides, polymyxins, β-lactams, tetracyclines, glycylcyclines, quinolones and metronidazole against the efflux pumps under study. Our results revealed that class polymyxins has the highest binding affinity with the RND efflux pumps i.e. AcrAB-TolC and AdeABC as well as non-RND efflux pump (NorM). The experimental data was found to much extent in accordance with the binding free energy scores obtained from our in silico analysis. To recapitulate the outcome, polymyxins can possibly be the most efficient substrate for both RND and non-RND efflux pumps, thus, can be used as a reference drug for designing potent efflux pump inhibitors against multi-drug resistant strains.
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Correlation of in-silico results with experimental results

272
The experimental data (Fig 7) gives the MIC values for the various drugs against AdeABC and 273 AcrAB-TolC efflux pumps. The MIC of Aminoglycosides (gentamycin) was found be 1μg/ml in 274 Yersinia pestis strain whereas its mutant strain with deleted AcrAB efflux gene (ΔacrAB) marks 275 the decrease in MIC (0.5 μg/ml) by 50% ((Ida M Lister et al.,2012). Ampicillin, a commonly
276 known β-lactam shows the MIC as 0.125 μg/ml in the wild type strain of Yersinia pestis whereas 277 in its mutant strain (ΔacrAB), the MIC of ampicillin was found to be 0.05 μg/ml which is much 310 RND as well as non-RND efflux pumps which implies the highest affinity of this class of drugs.
311 The present study proposed that polymyxins being able to bind efficiently with the efflux pump 312 components can be used as the reference drug to design inhibitors against the resistant strains 313 with efflux pumps as resistance determinants. Therefore, our result signifies the use of 314 polymyxins as attractive future drugs which can be modified in such a way that it can be used 315 alone to control the multidrug resistant strains of Acinetobacter baumanii rather than being 316 involved in any combinatorial therapy. 
